Login to Your Account



IntraBiotics Acquires Apothogen, Gets New CEO, Marketing Core

By Brady Huggett


Friday, April 26, 2002
Late-stage products are valuable, even ones with a somewhat troubled history. IntraBiotics Pharmaceuticals Inc.’s iseganan, in Phase III development, was enough to attract industry veteran Ernest Mario as its new CEO and chairman, a move accomplished by IntraBiotics acquiring Apothogen Inc., the company he founded. (BioWorld Today)

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription